These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Fibrosing cholestatic hepatitis after successful interferon and ribavirin therapy for recurrent hepatitis C post living related liver transplantation: a case report. Yamamoto T; Tanaka S; Uenishi T; Kanazawa A; Kubo S; Hirohashi K Osaka City Med J; 2014 Dec; 60(2):95-100. PubMed ID: 25803885 [TBL] [Abstract][Full Text] [Related]
26. Tissue quantification of hepatitis C virus RNA with morphologic correlation in the diagnosis of recurrent hepatitis C virus in human liver transplants. Aardema KL; Nakhleh RE; Terry LK; Burd EM; Ma CK; Moonka DK; Brown KA; Abouljoud MS Mod Pathol; 1999 Nov; 12(11):1043-9. PubMed ID: 10574601 [TBL] [Abstract][Full Text] [Related]
28. Prediction of liver allograft fibrosis after transplantation for hepatitis C virus: persistent elevation of serum transaminase levels versus necroinflammatory activity. Pelletier SJ; Iezzoni JC; Crabtree TD; Hahn YS; Sawyer RG; Pruett TL Liver Transpl; 2000 Jan; 6(1):44-53. PubMed ID: 10648577 [TBL] [Abstract][Full Text] [Related]
29. Delayed onset of severe hepatitis C-related liver damage following liver transplantation: a matter of concern? Berenguer M; Aguilera V; Prieto M; Carrasco D; Rayón M; San Juan F; Landaverde C; Mir J; Berenguer J Liver Transpl; 2003 Nov; 9(11):1152-8. PubMed ID: 14586875 [TBL] [Abstract][Full Text] [Related]
30. Morphologic features of hepatitis C recurrence in patients after orthotopic liver transplantation-preliminary analysis of our case observations. Ziarkiewicz-Wróblewska B; Górnicka B; Ołdakowska-Jedynak U; Bogdańska M; Wróblewski T; Morton M; Ziółkowski J; Paczek L; Krawczyk M; Wasiutyński A Transplant Proc; 2006; 38(1):226-30. PubMed ID: 16504709 [TBL] [Abstract][Full Text] [Related]
31. The prevalence and natural history of untreated isolated central perivenulitis in adult allograft livers. Krasinskas AM; Demetris AJ; Poterucha JJ; Abraham SC Liver Transpl; 2008 May; 14(5):625-32. PubMed ID: 18433038 [TBL] [Abstract][Full Text] [Related]
32. Quantitative analysis of portal tract infiltrate allows for accurate determination of hepatic allograft rejection. Sankary H; Foster P; Novich K; Ashmann M; Bhattacharyya A; Coleman J; Williams J Am J Surg; 1991 Jan; 161(1):131-4; discussion 134-5. PubMed ID: 1987847 [TBL] [Abstract][Full Text] [Related]
33. Seeking beyond rejection: an update on the differential diagnosis and a practical approach to liver allograft biopsy interpretation. Gao ZH Adv Anat Pathol; 2009 Mar; 16(2):97-117. PubMed ID: 19550371 [TBL] [Abstract][Full Text] [Related]
34. Quantitative evaluation of histological features in "time-zero" liver allograft biopsies as predictors of rejection or graft failure: receiver-operating characteristic analysis application. Abraham S; Furth EE Hum Pathol; 1996 Oct; 27(10):1077-84. PubMed ID: 8892594 [TBL] [Abstract][Full Text] [Related]
35. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients. Cosio FG; Sedmak DD; Henry ML; Al Haddad C; Falkenhain ME; Elkhammas EA; Davies EA; Bumgardner GL; Ferguson RM Transplantation; 1996 Oct; 62(8):1054-9. PubMed ID: 8900300 [TBL] [Abstract][Full Text] [Related]
36. Role of liver allograft biopsy in patient management. Williams JW; Foster PF; Sankary HN Semin Liver Dis; 1992 Feb; 12(1):60-72. PubMed ID: 1570552 [TBL] [Abstract][Full Text] [Related]
37. Histological Spectrum of Idiopathic Noncirrhotic Portal Hypertension in Liver Biopsies From Dialysis Patients. Lee H; Ainechi S; Singh M; Ells PF; Sheehan CE; Lin J Int J Surg Pathol; 2015 Sep; 23(6):439-46. PubMed ID: 25882443 [TBL] [Abstract][Full Text] [Related]